The global apheresis devices market has the potential to grow by USD 812.44 million during 2020-2024, and the market’s growth momentum will accelerate throughout the forecast period.

Theglobalapheresis devices market is expected to grow at a CAGR of 6.26% duringthe forecast period. Major vendors in the global apheresis devices marketinclude Asahi Kasei Corp., B. Braun Melsungen AG, Cerus Corp.,Fresenius Medical Care AG & Co. KGaA, Haemonetics Corp., HemaCare Corp., Kaneka Corp., Kawasumi LaboratoriesInc., Nikkiso Co. Ltd., and Terumo Corp., among others. 

 microscope-3184432_640.jpg (640×428)

GetFree Sample


Vendors are focusing on variousstrategies such as M&As and partnerships to expand their reach in themarket. For instance, Asahi Kasei Corp., in October 2019, the company acquired ViruSure GmbH,a provider of biosafety testing services. B. Braun Melsungen AG, in July 2019, the company acquired business operationsof Nephtec GmbH.This acquisition helped the company to strengthen its product offerings in thearea of dialysis concentrates. 


Similarly, Cerus Corp.,in October2017, the company established an agreement with Centro de Transfusión dela Comunidad deMadrid (CTCM) for INTERCEPT Blood System for platelets. FreseniusMedical Care AG & Co. KGaA, in February 2019, the company acquired NxStage MedicalInc., a manufacturer of systems for the treatment of chronic kidney disease,acute kidney injury, and hypervolemia. Hence, the increasing number of M&As andpartnerships among vendors is expected to boost the growth of the globalapheresis devices market during the forecast period. 


Browse Full Report-